Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
34,100
Employees34,100
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
34,100
Employees34,100

BMY Key Statistics

Market cap
88.33B
Market cap88.33B
Price-Earnings ratio
17.60
Price-Earnings ratio17.60
Dividend yield
5.64%
Dividend yield5.64%
Average volume
16.02M
Average volume16.02M
High today
$43.93
High today$43.93
Low today
$43.22
Low today$43.22
Open price
$43.76
Open price$43.76
Volume
12.39M
Volume12.39M
52 Week high
$63.33
52 Week high$63.33
52 Week low
$42.96
52 Week low$42.96

BMY News

Simply Wall St 4h
Does Bristol Myers Stock Offer Value as AI Data-Sharing Alliance Makes Headlines?

If you’re holding Bristol-Myers Squibb or eyeing it as a potential buy, you’re not alone in wondering what move makes sense right now. The stock has tested even...

Does Bristol Myers Stock Offer Value as AI Data-Sharing Alliance Makes Headlines?
TipRanks 10h
Neutral Outlook for Bristol-Myers Squibb Amidst Competitive Pressures and Growth Challenges

Tim Anderson, an analyst from Bank of America Securities, reiterated the Hold rating on Bristol-Myers Squibb. The associated price target remains the same with...

Nasdaq 1d
BMY Factor-Based Stock Analysis

Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our P/B Growth Invest...

BMY Factor-Based Stock Analysis

Analyst ratings

69%

of 29 ratings
Buy
27.6%
Hold
69%
Sell
3.4%

More BMY News

Simply Wall St 3d
What Bristol-Myers Squibb's FDA Fast Track for Alzheimer’s Drug Means for Shareholders

Earlier this month, Bristol-Myers Squibb announced that the US FDA granted Fast Track designation to its experimental Alzheimer's treatment BMS-986446, currentl...

What Bristol-Myers Squibb's FDA Fast Track for Alzheimer’s Drug Means for Shareholders
Barchart 3d
What to Expect From Bristol-Myers Squibb's Next Quarterly Earnings Report

Princeton, New Jersey-based Bristol-Myers Squibb Company ( BMY ) is one of the leading biopharmaceutical companies focused on developing treatments for diseases...

Simply Wall St 5d
Bristol-Myers Squibb: Exploring Valuation After Recent Share Price Declines

Bristol-Myers Squibb (BMY) shares have seen steady declines over the past month, with the stock ending yesterday at $43.96. Investors are taking a closer look a...

Bristol-Myers Squibb: Exploring Valuation After Recent Share Price Declines
Nasdaq 5d
BMY Quantitative Stock Analysis

Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Low PE Investor m...

BMY Quantitative Stock Analysis
TipRanks 6d
Bristol Myers Squibb Stock Slips on $1.5B Orbital Therapeutics Deal

Bristol Myers Squibb (BMY) stock was down on Friday after the biopharmaceutical company announced its acquisition of private biotechnology company Orbital Thera...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.